Cvs Health Shares Outstanding History (CVS)
Cvs Health reported 1.27B shares outstanding at the end of fiscal 2025.
View full Cvs Health company overviewCvs Health annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.27B | 11.0M | +0.87% |
| 2024 | 2024-12-31 | 1.26B | −28.0M | −2.17% |
| 2023 | 2023-12-31 | 1.29B | −12.0M | −0.92% |
| 2022 | 2022-12-31 | 1.30B | −22.0M | −1.66% |
| 2021 | 2021-12-31 | 1.32B | 12.0M | +0.92% |
| 2020 | 2020-12-31 | 1.31B | 8.0M | +0.61% |
| 2019 | 2019-12-31 | 1.30B | 7.0M | +0.54% |
| 2018 | 2018-12-31 | 1.29B | 281.0M | +27.71% |
| 2017 | 2017-12-31 | 1.01B | −47.0M | −4.43% |
| 2016 | 2016-12-31 | 1.06B | −40.0M | −3.63% |
| 2015 | 2015-12-31 | 1.10B | −39.0M | −3.42% |
| 2014 | 2014-12-31 | 1.14B | −40.0M | −3.39% |
| 2013 | 2013-12-31 | 1.18B | −51.0M | −4.14% |
| 2012 | 2012-12-31 | 1.23B | −67.0M | −5.16% |
| 2011 | 2011-12-31 | 1.30B | −65.0M | −4.77% |
| 2010 | 2010-12-31 | 1.36B | −28.0M | −2.01% |
| 2009 | 2009-12-31 | 1.39B | −45.0M | −3.13% |
| 2008 | 2008-12-31 | 1.44B | — | — |
Cvs Health quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.28B | 11.0M | +0.87% |
| Q1 2026 | 2026-03-31 | 1.27B | 11.0M | +0.87% |
| Q4 2025 | 2025-12-31 | 1.27B | 11.0M | +0.87% |
| Q3 2025 | 2025-09-30 | 1.27B | 12.0M | +0.95% |
| Q2 2025 | 2025-06-30 | 1.27B | 11.0M | +0.88% |
| Q1 2025 | 2025-03-31 | 1.26B | 10.0M | +0.80% |
| Q4 2024 | 2024-12-31 | 1.26B | −28.0M | −2.17% |
| Q3 2024 | 2024-09-30 | 1.26B | −29.0M | −2.25% |
| Q2 2024 | 2024-06-30 | 1.26B | −26.0M | −2.03% |
| Q1 2024 | 2024-03-31 | 1.25B | −27.0M | −2.11% |
| Q4 2023 | 2023-12-31 | 1.29B | −12.0M | −0.92% |
| Q3 2023 | 2023-09-30 | 1.29B | −28.0M | −2.13% |
| Q2 2023 | 2023-06-30 | 1.28B | −30.0M | −2.29% |
| Q1 2023 | 2023-03-31 | 1.28B | −27.0M | −2.07% |
| Q4 2022 | 2022-12-31 | 1.30B | −22.0M | −1.66% |
| Q3 2022 | 2022-09-30 | 1.31B | −6.0M | −0.45% |
| Q2 2022 | 2022-06-30 | 1.31B | −6.0M | −0.46% |
| Q1 2022 | 2022-03-31 | 1.31B | −7.0M | −0.53% |
| Q4 2021 | 2021-12-31 | 1.32B | 12.0M | +0.92% |
| Q3 2021 | 2021-09-30 | 1.32B | 12.0M | +0.92% |
| Q2 2021 | 2021-06-30 | 1.32B | 11.0M | +0.84% |
| Q1 2021 | 2021-03-31 | 1.31B | 8.0M | +0.61% |
| Q4 2020 | 2020-12-31 | 1.31B | 8.0M | +0.61% |
| Q3 2020 | 2020-09-30 | 1.31B | 8.0M | +0.61% |
| Q2 2020 | 2020-06-30 | 1.31B | 8.0M | +0.62% |
| Q1 2020 | 2020-03-31 | 1.30B | 7.0M | +0.54% |
| Q4 2019 | 2019-12-31 | 1.30B | 7.0M | +0.54% |
| Q3 2019 | 2019-09-30 | 1.30B | 282.0M | +27.67% |
| Q2 2019 | 2019-06-30 | 1.30B | 282.0M | +27.73% |
| Q1 2019 | 2019-03-31 | 1.30B | 282.0M | +27.76% |
| Q4 2018 · Dec 31 | 2018-12-31 | 1.29B | 281.0M | +27.71% |
| Q3 2018 | 2018-09-30 | 1.02B | 6.0M | +0.59% |
| Q2 2018 | 2018-06-30 | 1.02B | 2.0M | +0.20% |
| Q1 2018 | 2018-03-31 | 1.02B | −11.0M | −1.07% |
| Q4 2017 · Dec 31 | 2017-12-31 | 1.01B | −47.0M | −4.43% |
| Q3 2017 | 2017-09-30 | 1.01B | −53.0M | −4.97% |
| Q2 2017 | 2017-06-30 | 1.01B | −50.0M | −4.69% |
| Q1 2017 | 2017-03-31 | 1.03B | −54.0M | −5.00% |
| Q4 2016 | 2016-12-31 | 1.06B | −40.0M | −3.63% |
| Q3 2016 | 2016-09-30 | 1.07B | −44.0M | −3.96% |
| Q2 2016 | 2016-06-30 | 1.06B | −53.0M | −4.74% |
| Q1 2016 | 2016-03-31 | 1.08B | −46.0M | −4.08% |
| Q4 2015 | 2015-12-31 | 1.10B | −39.0M | −3.42% |
| Q3 2015 | 2015-09-30 | 1.11B | −43.0M | −3.73% |
| Q2 2015 | 2015-06-30 | 1.12B | −42.0M | −3.62% |
| Q1 2015 | 2015-03-31 | 1.13B | −46.0M | −3.92% |
| Q4 2014 | 2014-12-31 | 1.14B | −40.0M | −3.39% |
| Q3 2014 | 2014-09-30 | 1.15B | −51.0M | −4.24% |
| Q2 2014 | 2014-06-30 | 1.16B | −67.0M | −5.46% |
| Q1 2014 | 2014-03-31 | 1.17B | −55.0M | −4.48% |
| Q4 2013 | 2013-12-31 | 1.18B | −51.0M | −4.14% |
| Q3 2013 | 2013-09-30 | 1.20B | −42.0M | −3.37% |
| Q2 2013 | 2013-06-30 | 1.23B | −44.0M | −3.46% |
| Q1 2013 | 2013-03-31 | 1.23B | −62.0M | −4.81% |
| Q4 2012 | 2012-12-31 | 1.23B | −67.0M | −5.16% |
| Q3 2012 | 2012-09-30 | 1.25B | −62.0M | −4.74% |
| Q2 2012 | 2012-06-30 | 1.27B | −75.0M | −5.57% |
| Q1 2012 | 2012-03-31 | 1.29B | −64.0M | −4.73% |
| Q4 2011 | 2011-12-31 | 1.30B | −65.0M | −4.77% |
| Q3 2011 | 2011-09-30 | 1.31B | −50.0M | −3.68% |
| Q2 2011 | 2011-06-30 | 1.35B | −10.0M | −0.74% |
| Q1 2011 | 2011-03-31 | 1.35B | −17.0M | −1.24% |
| Q4 2010 | 2010-12-31 | 1.36B | −28.0M | −2.01% |
| Q3 2010 | 2010-09-30 | 1.36B | −60.8M | −4.28% |
| Q2 2010 | 2010-06-30 | 1.36B | −80.0M | −5.57% |
| Q1 2010 | 2010-03-31 | 1.37B | — | — |
| Q4 2009 | 2009-12-31 | 1.39B | — | — |
| Q3 2009 | 2009-09-30 | 1.42B | — | — |
| Q4 2008 | 2008-12-31 | 1.44B | — | — |
Cvs Health shares outstanding trends
Over the last five reported fiscal years, Cvs Health's shares outstanding moved from 1.31B to 1.27B, a change of −39.0M. The latest reported quarter, Q2 2026, shows 1.28B.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cvs Health filings at SEC.gov ↗